Troglitazone, a new antidiabetic agent, decreases cyclosporine level

Journal of Heart and Lung Transplantation

Volumn 17, Issue 11, 1998, Pages 1139-1140

  Park, M H ^a   Pelegrin, D ^a   Haug III, M T ^a   Young, J B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TROGLITAZONE;

ADULT; AGED; CASE REPORT; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

AGED; CHROMANS; CYCLOSPORINE; DIABETES MELLITUS, TYPE 1; DRUG INTERACTIONS; HEART TRANSPLANTATION; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031765483     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)